136 related articles for article (PubMed ID: 17853254)
1. Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder.
Bozina N; Peles AM; Sagud M; Bilusic H; Jakovljevic M
World J Biol Psychiatry; 2008; 9(3):190-7. PubMed ID: 17853254
[TBL] [Abstract][Full Text] [Related]
2. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder.
Ruhé HG; Ooteman W; Booij J; Michel MC; Moeton M; Baas F; Schene AH
Pharmacogenet Genomics; 2009 Jan; 19(1):67-76. PubMed ID: 18987562
[TBL] [Abstract][Full Text] [Related]
3. The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.
Tomita T; Yasui-Furukori N; Nakagami T; Tsuchimine S; Ishioka M; Kaneda A; Sugawara N; Kaneko S
PLoS One; 2014; 9(5):e98099. PubMed ID: 24858363
[TBL] [Abstract][Full Text] [Related]
4. Serotonin transporter polymorphism in Croatian patients with major depressive disorder.
Bozina N; Mihaljević-Peles A; Sagud M; Jakovljević M; Sertić J
Psychiatr Danub; 2006 Jun; 18(1-2):83-9. PubMed ID: 16804504
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics in modern psychiatry.
Mihaljević-Peles A; Bozina N; Sagud M
Psychiatr Danub; 2007 Sep; 19(3):231-3. PubMed ID: 17914325
[TBL] [Abstract][Full Text] [Related]
6. Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients.
Lotrich FE; Pollock BG; Kirshner M; Ferrell RF; Reynolds Iii CF
J Psychiatry Neurosci; 2008 Mar; 33(2):123-30. PubMed ID: 18330458
[TBL] [Abstract][Full Text] [Related]
7. Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients.
Yoshimura R; Umene-Nakano W; Suzuki A; Ueda N; Miyamoto K; Ikenouchi-Sugita A; Hori H; Otani K; Nakamura J
Hum Psychopharmacol; 2009 Aug; 24(6):489-94. PubMed ID: 19606452
[TBL] [Abstract][Full Text] [Related]
8. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
[TBL] [Abstract][Full Text] [Related]
9. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
Manoharan A; Shewade DG; Rajkumar RP; Adithan S
Eur J Clin Pharmacol; 2016 Oct; 72(10):1215-1220. PubMed ID: 27439447
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Katsuki A; Atake K; Nakamura J
Hum Psychopharmacol; 2013 Sep; 28(5):466-70. PubMed ID: 23813968
[TBL] [Abstract][Full Text] [Related]
11. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
[TBL] [Abstract][Full Text] [Related]
12. Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders.
Serretti A; Cusin C; Rossini D; Artioli P; Dotoli D; Zanardi R
Am J Med Genet B Neuropsychiatr Genet; 2004 Aug; 129B(1):36-40. PubMed ID: 15274037
[TBL] [Abstract][Full Text] [Related]
13. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
[TBL] [Abstract][Full Text] [Related]
14. ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.
Kato M; Fukuda T; Serretti A; Wakeno M; Okugawa G; Ikenaga Y; Hosoi Y; Takekita Y; Mandelli L; Azuma J; Kinoshita T
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):398-404. PubMed ID: 17913323
[TBL] [Abstract][Full Text] [Related]
15. Serotonin transporter polymorphism and bleeding time during SSRI therapy.
Hougardy DM; Egberts TC; van der Graaf F; Brenninkmeijer VJ; Derijks LJ
Br J Clin Pharmacol; 2008 May; 65(5):761-6. PubMed ID: 18279474
[TBL] [Abstract][Full Text] [Related]
16. Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder.
Simoons M; Mulder H; Appeldoorn JTY; Risselada AJ; Schene AH; van Schaik RHN; van Roon EN; Ruhé EG
Psychiatr Genet; 2020 Feb; 30(1):19-29. PubMed ID: 31634334
[TBL] [Abstract][Full Text] [Related]
17. Association of 2 neurotrophic factor polymorphisms with efficacy of paroxetine in patients with major depressive disorder in a Chinese population.
Wang XC; Xu DJ; Chen GH; Xia Q; Liu LN
Ther Drug Monit; 2014 Oct; 36(5):612-7. PubMed ID: 24577123
[TBL] [Abstract][Full Text] [Related]
18. Association between functional polymorphisms in serotonin transporter gene (SLC6A4) and escitalopram treatment response in depressive patients in a South Indian population.
Mandal T; Bairy LK; Sharma PSVN
Eur J Clin Pharmacol; 2020 Jun; 76(6):807-814. PubMed ID: 32253447
[TBL] [Abstract][Full Text] [Related]
19. SERT and NET polymorphisms, temperament and antidepressant response.
Andre K; Kampman O; Illi A; Viikki M; Setälä-Soikkeli E; Mononen N; Lehtimäki T; Haraldsson S; Koivisto PA; Leinonen E
Nord J Psychiatry; 2015; 69(7):531-8. PubMed ID: 25739526
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism in the serotonin transporter gene-linked polymorphic region and response to serotonin reuptake inhibitors in patients with premature ejaculation.
Ozbek E; Otunctemur A; Simsek A; Polat EC; Ozcan L; Köse O; Cekmen M
Clinics (Sao Paulo); 2014 Nov; 69(11):710-3. PubMed ID: 25518026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
